Paediatric and Nephrourology: Literature
Scintigraphy of the Paediatric Skeleton
We are providing a link to the Scintigraphy of the Paediatric Skeleton.
This site contains a fully searchable database of bone atlas scans and diagnosis. This online resource has been designed for the use of practitioners and students of scintigraphic scanning techniques.
The development of this web site follows the publication of two atlases of Bone Scintigraphy in Paediatrics produced under the auspices of the Paediatric Committee of the European Association of Nuclear Medicine.
Fahey F, Zukotynski K, Zurakowski D, Markelewicz R, Falone A, Vitello M, Cao X, Grant F, Drubach L, Vija AH, Bhattacharya M, Ding X, Bar-Sever Z, Gelfand M, Treves ST.
Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy.
Eur J Nucl Med Mol Imaging. 2014 Aug 6.
Schäfer JF, Gatidis S, Schmidt H, Gückel B, Bezrukov I, Pfannenberg CA, Reimold M, Ebinger M, Fuchs J, Claussen CD, Schwenzer NF.
Simultaneous Whole-Body PET/MR Imaging in Comparison to PET/CT in Pediatric Oncology: Initial Results.
Radiology. 2014 May 31:131732.
Blokhuis GJ, Bleeker-Rovers CP, Diender MG, Oyen WJ, Draaisma JM, de Geus-Oei LF.
Diagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression.
Eur J Nucl Med Mol Imaging. 2014 May 29.
Markovina S, Grigsby PW, Schwarz JK, DeWees T, Moley JF, Siegel BA, Perkins SM.
Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence.
Thyroid. 2014 Jul;24(7):1121-6.
Stanescu L, Ishak GE, Khanna PC, Biyyam DR, Shaw DW, Parisi MT.
FDG PET of the brain in pediatric patients: imaging spectrum with MR imaging correlation.
Radiographics. 2013 Sep-Oct;33(5):1279-303.
Newman EN, Jones RL, Hawkins DS.
An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.
Pediatr Blood Cancer. 2013 Jul;60(7):1113-7
Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L.
Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.
Skeletal Radiol. 2012 Mar;41(3):249-56. doi: 10.1007/s00256-011-1298-9. Epub 2011 Nov 10.
Rapkin L, Pashankar FD.
Management of thyroid carcinoma in children and young adults.
J Pediatr Hematol Oncol. 2012 May;34 Suppl 2:S39-46.
Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, Bartenstein P, Pfluger T.
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1648-58.
Ricard F, Cimarelli S, Deshayes E, Mognetti T, Thiesse P, Giammarile F.
Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
Clin Nucl Med. 2011 Aug;36(8):672-7.
Piepsz A.
Functional renal imaging: new trends in radiology and nuclear medicine.
Semin Nucl Med. 2011 Jan;41(1):61-72.
Durand E, Chaumet-Riffaud P, Grenier N.
Antenatal detection of pelviureteric junction stenosis: main controversies.
Semin Nucl Med. 2011 Jan;41(1):11-9.
Naranjo A, Parisi MT, Shulkin BL, London WB, Matthay KK, Kreissman SG, Yanik GA.
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
Pediatr Blood Cancer. 2011 Jul 1;56(7):1041-5.
Franzius C.
FDG-PET/CT in pediatric solid tumors.
Q J Nucl Med Mol Imaging. 2010 Aug;54(4):401-10.
Piepsz A, Sixt R, Gordon I.
Performing renography in children with antenatally detected pelvi-ureteric junction stenosis: errors, pitfalls, controversies.
Q J Nucl Med Mol Imaging. 2010 Aug;54(4):350-62.
Jacobson AF1, Deng H, Lombard J, Lessig HJ, Black RR.
123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis.
J Clin Endocrinol Metab. 2010 Jun;95(6):2596-606.
Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, Pearson AD, Cohn SL.
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
Br J Cancer. 2010 Apr 27;102(9):1319-26. doi: 10.1038/sj.bjc.6605621. Review.
Balamuth NJ, Womer RB.
Ewing's sarcoma.
Lancet Oncol. 2010 Feb;11(2):184-92.
Bestic JM, Peterson JJ, Bancroft LW.
Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected].
Radiographics. 2009 Sep-Oct;29(5):1487-500. Erratum in: Radiographics. 2010 Jan-Feb;30(1):301.
Vassal G, Giammarile F, Brooks M, Geoerger B, Couanet D, Michon J, Stockdale E, Schell M, Geoffray A, Gentet JC, Pichon F, Rubie H, Cisar L, Assadourian S, Morland B.
A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: a European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG).
Eur J Cancer. 2008 Nov;44(16):2453-60.
Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H.
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
J Clin Oncol. 2007 Dec 1;25(34):5435-41.
Angelini P, De Bernardi B, Granata C, Villavecchia G, Morbelli S, Luksch R, Di Cataldo A, Garaventa A, Castellani R.
Skeletal involvement in infants with neuroblastoma a quality control attempt.
Tumori. 2007 Jan-Feb;93(1):82-7.
Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA, Matthay KK.
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
Pediatr Blood Cancer. 2006 Dec;47(7):865-74.
Mody RJ, Pohlen JA, Malde S, Strouse PJ, Shulkin BL.
FDG PET for the study of primary hepatic malignancies in children.
Pediatr Blood Cancer. 2006 Jul;47(1):51-5.
Kushner BH1, Yeh SD, Kramer K, Larson SM, Cheung NK.
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
J Clin Oncol. 2003 Mar 15;21(6):1082-6.
Giammarile F, Lumbroso J, Ricard M, Aubert B, Hartmann O, Schlumberger M, Parmentier C.
Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.
Eur J Nucl Med. 1995 Oct;22(10):1180-3.